One of the world's largest pharmaceutical companies, Merck KGaA (ETR: MRK), has reiterated its commitment to its partnership with the Ugandan government via its non-profit subsidiary Merck Foundation, Pharmafile reported on Tuesday.
The partnership aims to bolster the country's healthcare abilities and treatment access in the region, with a particular emphasis in areas concerning cancer, cardiovascular disease, diabetes and infertility.
The 'Merck more than a mother' project was first launched in 2012.
"Raising awareness about male infertility is very important to change the culture as [it] affects women and men equally and yet women are the one who been solely blamed, discriminated and mistreated in their communities," commented Merck Foundation CEO Dr Rasha Kelej.
"The campaign will address this topic and encourage men to discuss openly their infertility and share the journey of infertility diagnosis and treatment with their wives."
Medicomp Systems client IJN in Malaysia granted Stage 7 validation from HIMSS EMRAM
Precision BioSciences receives FDA Fast Track designation for PBGENE-DMD
GAIA and Daiichi Sankyo Europe partner on digital therapeutic for cardiovascular care
Esperion to acquire Corstasis, expanding cardiovascular portfolio
Circio reports up to 50-fold gene expression gain in eye for circVec-AAV platform
Celyad Oncology sells C-Cathez catheter to CellProthera
Realheart secures European patent for artificial heart technology
Cumberland Pharmaceuticals secures FDA Fast Track status for DMD heart‑disease therapy ifetroban
Kestra partners with Biobeat to add cuffless blood pressure monitoring to wearable defibrillator
Organon signs commercialisation agreement for Nilemdo across six European markets
Antin to acquire clinical trial equipment provider Emsere
GSK wins European Commission approval for Shingrix prefilled syringe